Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | Suppliers

Novo Nordisk Pharmatech A/S - Insulin Human and Benzalkonium Chloride Products News

Novo Nordisk Pharmatech A/S - Insulin Human and Benzalkonium Chloride Products

Novo Nordisk Pharmatech enters important distribution agreement with Azelis for pharmaceutical grade quaternary ammonium compounds Novo Nordisk Pharmatech A/S has entered into an agreement with Azelis for the distribution of pharmaceutical grade quaternary ammonium compounds (quats) to the pharmaceutical and medical device markets in Germany, Spain Portugal, UK and Ireland.
View press release
Novo Nordisk Pharmatech A/S Attending Upcoming Exhibitions and Conferences Novo Nordisk Pharmatech A/S, part of Novo Nordisk, specialises in supplying ingredients to the biopharmaceutical and pharmaceutical industries.This October it will be participating in the CPHI worldwide exhibition in Barcelona, and BioProcess International USA conference and exhibition.
View press release
Novo Nordisk Pharmatech Now Distributing with Brenntag Specialities Novo Nordisk Pharmatech A/S and Brenntag Specialties, Inc. (BSI) have entered into a distribution agreement for Pharmaceutical Grade Quaternary Ammonium Compounds into the Pharmaceutical, Over-the-Counter (OTC), and Personal Care Markets in the United States and Puerto Rico.
View press release
Novo Nordisk Pharmatech A/S - Delivering Excellence at Every Step Novo Nordisk Pharmatech A/S is a leading global supplier of high-quality ingredients for the biopharmaceutical and pharmaceutical industries. The company has attracted an extensive roster of leading pharmaceutical companies through unsurpassed product quality, manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation strategy.
View press release
FeF Chemicals A/S to Change to Novo Nordisk Pharmatech A/S and makes the Transfer to SAP Fef Chemicals A/S has confirmed that it will change its name to Novo Nordisk Pharmatech A/S as of September 1st 2015.
View press release
New US Distribution Center for Insulin Human AF To provide the best possible customer service we now offer distribution from two separate warehouse locations; the new distribution facility located in Plainfield, Indiana, USA, and our facility located near Copenhagen, Denmark. These two distribution centers, respectively serve, the US market and the rest of the world.
View press release
JP Compliant Products Available In a continuous effort to respond to increasingly demanding market needs, FeF Chemicals offers JP (Japanese Pharmacopoeia) compliant products.
View press release
FeF Chemicals Now ISO 18001 Certified We are proud to announce that we have achieced an OHSAS (occupational health and safety DS/EN ISO 18001 certification of our quality and environment control system and as a result, it is an intergrated part of our daily work.
View press release
FeF Chemicals Add CTAB USP/NF to cGMP Manufactured Products' Portfolio In response to the increasing demand for cGMP manufactured quats, FeF Chemicals is now able to offer Cetrimonium Bromide (Cetyl Trimethyl Ammonium Bromide, CTAB) in pharmaceutical quality.
View press release